Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome

American Society for Clinical Investigation, Journal of Clinical Investigation, 3(132), 2022

Journal article published in 2022 by David S. Perlin

, H. Jeffrey Wilkins

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving forbidden

Postprint: archiving forbidden

Published version: archiving allowed

Upload

Policy details

Data provided by